HuR regulates beta-tubulin isotype expression in ovarian cancer
about
MiR-200c and HuR in ovarian cancerClass III β-tubulin counteracts the ability of paclitaxel to inhibit cell migrationThe miR-200 Family: Versatile Players in Epithelial Ovarian CancerFree testosterone drives cancer aggressiveness: evidence from US population studiesmiR-200c Regulation of Metastases in Ovarian Cancer: Potential Role in Epithelial and Mesenchymal TransitionClass III β-tubulin and the cytoskeletal gateway for drug resistance in ovarian cancerβIII-Tubulin: biomarker of taxane resistance or drug target?Multiple functions of the RNA-binding protein HuR in cancer progression, treatment responses and prognosisMicrotubules and their role in cellular stress in cancerHGF/c-Met axis drives cancer aggressiveness in the neo-adjuvant setting of ovarian cancerThe ADNP derived peptide, NAP modulates the tubulin pool: implication for neurotrophic and neuroprotective activitiesβIII-tubulin: a novel mediator of chemoresistance and metastases in pancreatic cancerRole and prognostic significance of the epithelial-mesenchymal transition factor ZEB2 in ovarian cancer.HuR-regulated lncRNA NEAT1 stability in tumorigenesis and progression of ovarian cancerPost-transcriptional controls by ribonucleoprotein complexes in the acquisition of drug resistance.Delineating the Role of βIV-Tubulins in Pancreatic Cancer: βIVb-Tubulin Inhibition Sensitizes Pancreatic Cancer Cells to Vinca Alkaloids.Human antigen R as a predictive marker for response to gemcitabine-based chemotherapy in advanced cisplatin-resistant urothelial cancer.Clinical significance of HuR expression in human malignancy.βIII-Tubulin alters glucose metabolism and stress response signaling to promote cell survival and proliferation in glucose-starved non-small cell lung cancer cells.HuR is a post-transcriptional regulator of core metabolic enzymes in pancreatic cancer.An Emerging Role for Tubulin Isotypes in Modulating Cancer Biology and Chemotherapy ResistanceExpression of ERCC1, RRM1, TUBB3 in correlation with apoptosis repressor ARC, DNA mismatch repair proteins and p53 in liver metastasis of colorectal cancer.Modulation of the mRNA-binding protein HuR as a novel reversal mechanism of epirubicin-triggered multidrug resistance in colorectal cancer cellsTUBB3 overexpression has a negligible effect on the sensitivity to taxol in cultured cell lines.Predictive and prognostic significance of cytoplasmic expression of ELAV-like protein HuR in invasive breast cancer treated with neoadjuvant chemotherapy.HuR cytoplasmic expression is associated with increased cyclin A expression and inferior disease-free survival in patients with gastrointestinal stromal tumours (GISTs).The RNA-binding protein HuR inhibits expression of CCL5 and limits recruitment of macrophages into tumors.Human antigen R mediated post-transcriptional regulation of epithelial-mesenchymal transition related genes in diabetic nephropathy.Prognostic value of vascular endothelial growth factor receptor 1 and class III β-tubulin in survival for non-metastatic rectal cancer
P2860
Q21261258-FBEA29FB-010F-44B3-952A-32E5ADCE6D48Q24617268-F25131A5-BDD8-4FEB-8211-DF1A2A46BF68Q26799353-C40942F5-9741-4B60-B155-215EBBE9B0E3Q27324026-A7A128E9-0158-4CDC-A57F-F325C2423D4BQ28071987-5B832405-AD80-4BE8-ADA2-327545732F4FQ28236320-68030395-C1AB-4C1A-894D-0F0D49709BCBQ28284878-42C629A5-DC03-4C43-A062-BEBC2EB280FFQ28290458-941EF786-C289-4DE1-9F8D-DF2561232375Q33770927-B9CD97C1-4DEA-4EF7-A781-6510CFC3D583Q34104074-B06DF227-21CB-4946-BB47-231724EA0A6EQ34525286-3309462B-2338-4E1D-A446-436E0DD37A4EQ35273536-A29D014A-C602-4067-8F2D-2B942AF6A1D5Q36326301-440F087A-148A-4CFF-A334-55E097ED2B69Q37094937-A889C131-70F5-48E3-ACBE-4C54436B8399Q37139289-FA959053-AF6E-4457-A3C7-3DCE09061A03Q37447324-737F8B92-3525-47E6-864F-26EE28517693Q37701162-BB9BA4A5-BA84-4DBD-95E3-AF5601B5FBBBQ38238932-B5485395-9739-436D-88AB-8945A447E8FAQ38769519-EC3DB58B-82D7-4781-8648-67264605ED0FQ39133952-2E9E7B23-D7E9-4A54-B3F8-11B78E209897Q39414846-EC924E37-273A-465E-A65C-3C834B8659E3Q42084826-82928C4C-9830-4D4C-8C92-BDF979C74D70Q42368968-F074CC64-399F-40DD-A3F7-45D9A5D86648Q42700928-608CAC88-2E4E-435E-B09B-9144D2EE9433Q45929654-751444AC-EE04-41DC-B587-2BE928A032E0Q47929181-5B75C13C-287D-4AED-9BD5-BFF18FB9086CQ48088391-EB49EDCF-3F48-4F2F-B4A0-98E69BBD2700Q51694546-7F6DCD17-FCAC-43B2-99F1-AF2519739460Q58566654-5870E387-FE9E-4592-A914-322B75C7B329
P2860
HuR regulates beta-tubulin isotype expression in ovarian cancer
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
HuR regulates beta-tubulin isotype expression in ovarian cancer
@ast
HuR regulates beta-tubulin isotype expression in ovarian cancer
@en
HuR regulates beta-tubulin isotype expression in ovarian cancer
@nl
type
label
HuR regulates beta-tubulin isotype expression in ovarian cancer
@ast
HuR regulates beta-tubulin isotype expression in ovarian cancer
@en
HuR regulates beta-tubulin isotype expression in ovarian cancer
@nl
prefLabel
HuR regulates beta-tubulin isotype expression in ovarian cancer
@ast
HuR regulates beta-tubulin isotype expression in ovarian cancer
@en
HuR regulates beta-tubulin isotype expression in ovarian cancer
@nl
P50
P3181
P1433
P1476
HuR regulates beta-tubulin isotype expression in ovarian cancer
@en
P2093
Cristiano Ferlini
Enrica Martinelli
P304
P3181
P356
10.1158/0008-5472.CAN-09-4656
P407
P50
P577
2010-07-15T00:00:00Z